PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 93 filers reported holding PMV PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,813 | -1.9% | 11,533 | 0.0% | 0.02% | +14.3% |
| Q2 2023 | $72,197 | +31.2% | 11,533 | 0.0% | 0.02% | +10.5% |
| Q1 2023 | $55,012 | -45.2% | 11,533 | 0.0% | 0.02% | -44.1% |
| Q4 2022 | $100,337 | -26.8% | 11,533 | 0.0% | 0.03% | -24.4% |
| Q3 2022 | $137,000 | -16.5% | 11,533 | 0.0% | 0.04% | -16.7% |
| Q2 2022 | $164,000 | -31.7% | 11,533 | 0.0% | 0.05% | +10.2% |
| Q1 2022 | $240,000 | -9.8% | 11,533 | 0.0% | 0.05% | +44.1% |
| Q4 2021 | $266,000 | +16.2% | 11,533 | +49.9% | 0.03% | +54.5% |
| Q3 2021 | $229,000 | -12.9% | 7,692 | 0.0% | 0.02% | -12.0% |
| Q2 2021 | $263,000 | +4.0% | 7,692 | 0.0% | 0.02% | -26.5% |
| Q1 2021 | $253,000 | – | 7,692 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
| Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
| OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
| Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
| Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
| Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
| Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
| RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
| HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |